HS-IT101 Injection for Advanced NSCLC

NCT07105176 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

12

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Non-Small Cell Lung Cancer

Interventions

DRUG: Cyclophosphamide
DRUG: Fludarabine
DRUG: IL-2 (interleukin 2)
DRUG: HS-IT101 monotherapy

Sponsor

Qingdao Sino-Cell Biomedicine Co., Ltd.